Steven Cohen’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$157K Sell
77,502
-79,984
-51% -$221K ﹤0.01% 3561
2026
Q2
$408K Buy
+157,486
New +$466K ﹤0.01% 3267
2026
Q1
– Sell
-278,018
Closed -$990K – 3776
2025
Q4
$990K Buy
+278,018
New +$1.7M ﹤0.01% 2883

Other funds holding AVXL

Steven Cohen's AVXL Position: Q3 2026 in Review

Steven Cohen reduced its Anavex Life Sciences (AVXL) stake by 51% in Q3 2026, selling an estimated $221K and leaving 77,502 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

Steven Cohen first reported a position in AVXL in Q4 2025 and has held it in 3 quarters since. The position peaked at $990K in Q4 2025. 167 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Steven Cohen held 77,502 shares of Anavex Life Sciences worth $157K as of Q3 2026.
  • Steven Cohen sold 79,984 Anavex Life Sciences shares in Q3 2026, an estimated $221K.
  • Anavex Life Sciences made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3561 holding.
  • Steven Cohen first reported a position in Anavex Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Steven Cohen's Anavex Life Sciences position peaked at $990K in Q4 2025.
  • 167 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.